Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
Leonie Maria FrommertAmanthi Nadira Arumahandi de SilvaJan ZernickeVeronika ScholzTanja BraunLara Maria JeworowskiTatjana SchwarzPinkus Tober-LauAlexander Ten HagenElisa HabermannFlorian KurthLeif-Erik SanderVictor Max CormanGerd-Rüdiger R BurmesterRobert BiesenFredrik Nils AlbachJens KlotschePublished in: RMD open (2023)
Certain immunosuppressive therapies are associated with lower antibody responses after vaccination. Additional factors such as vaccine type, age and vaccination interval should be taken into account. We recommend antibody testing in at-risk patients with AIRD and emphasise the importance of booster vaccinations in these patients.